HUMANA INC (HUM) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-03-31..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-03-31..
Cash and securities
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 4.95B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Quarter-end shares | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-03-31 | (m) | (m) | $4.95B | (m) | (m) |
| 2025-12-31 | (m) | (m) | $4.20B | (m) | (m) |
| 2025-09-30 | (m) | (m) | $5.39B | (m) | (m) |
| 2025-06-30 | (m) | (m) | $4.04B | (m) | (m) |
| 2025-03-31 | (m) | (m) | $4.25B | (m) | (m) |
| 2024-12-31 | (m) | (m) | $2.22B | (m) | (m) |
| 2024-09-30 | (m) | (m) | $5.12B | (m) | (m) |
| 2024-06-30 | (m) | (m) | $5.50B | (m) | (m) |
| 2024-03-31 | (m) | (m) | $5.91B | (m) | (m) |
| 2023-12-31 | (m) | (m) | $4.69B | (m) | (m) |
| 2023-09-30 | (m) | (m) | $15.15B | (m) | (m) |
| 2023-06-30 | (m) | (m) | $16.21B | (m) | (m) |
| 2023-03-31 | (m) | (m) | $13.73B | (m) | (m) |
| 2022-12-31 | (m) | (m) | $5.06B | (m) | (m) |
| 2022-09-30 | (m) | (m) | $13.56B | (m) | (m) |
| 2022-06-30 | (m) | (m) | $5.15B | (m) | (m) |
| 2022-03-31 | (m) | (m) | $4.86B | (m) | (m) |
| 2021-12-31 | (m) | (m) | $3.39B | (m) | (m) |
| 2021-09-30 | (m) | (m) | $4.30B | (m) | (m) |
| 2021-06-30 | (m) | (m) | $3.38B | (m) | (m) |
| 2021-03-31 | (m) | (m) | $3.88B | (m) | (m) |
| 2020-12-31 | (m) | (m) | $4.67B | (m) | (m) |
| 2020-09-30 | (m) | (m) | $7.99B | (m) | (m) |
| 2020-06-30 | $20.00B | (m) | $7.16B | $12.84B | (m) |
| 2020-03-31 | $17.16B | (m) | $6.05B | $11.10B | (m) |
| 2019-12-31 | $15.03B | (m) | $4.05B | $10.97B | (m) |
| 2019-09-30 | $15.96B | (m) | $5.53B | $10.43B | (m) |
| 2019-06-30 | $14.77B | (m) | $4.78B | $9.99B | (m) |
| 2019-03-31 | $13.75B | (m) | $3.88B | $9.88B | (m) |
| 2018-12-31 | $12.37B | (m) | $2.34B | $10.03B | (m) |
| 2018-09-30 | $13.84B | (m) | $4.14B | $9.70B | (m) |
| 2018-06-30 | $17.52B | (m) | $8.05B | $9.46B | (m) |
| 2018-03-31 | $18.60B | (m) | $8.86B | $9.74B | (m) |
| 2017-12-31 | $13.60B | (m) | $4.04B | $9.56B | (m) |
| 2017-09-30 | $18.49B | (m) | $9.87B | $8.62B | (m) |
| 2017-06-30 | $16.25B | (m) | $8.14B | $8.12B | (m) |
| 2017-03-31 | $16.63B | (m) | $8.43B | $8.21B | (m) |
| 2016-12-31 | $11.47B | (m) | $3.88B | $7.59B | (m) |
| 2016-09-30 | $14.10B | (m) | $6.77B | $7.33B | (m) |
| 2016-06-30 | $9.85B | (m) | $2.43B | $7.42B | (m) |
| 2016-03-31 | $10.54B | (m) | $2.80B | $7.74B | (m) |
| 2015-12-31 | $9.84B | (m) | $2.57B | $7.27B | (m) |
| 2015-09-30 | $9.02B | (m) | $1.60B | $7.42B | (m) |
| 2015-06-30 | $9.29B | (m) | $2.25B | $7.04B | (m) |
| 2015-03-31 | $9.55B | (m) | $1.95B | $7.60B | (m) |
| 2014-12-31 | $9.53B | (m) | $1.94B | $7.60B | (m) |
| 2014-09-30 | $10.79B | (m) | $2.71B | $8.09B | (m) |
| 2014-06-30 | $9.16B | (m) | $1.59B | $7.57B | (m) |
| 2014-03-31 | $9.91B | (m) | $1.66B | $8.25B | (m) |
| 2013-12-31 | $9.23B | (m) | $1.14B | $8.09B | (m) |
| 2013-09-30 | $9.52B | (m) | $1.25B | $8.26B | (m) |
| 2013-06-30 | $9.07B | (m) | $1.52B | $7.56B | (m) |
| 2013-03-31 | $9.54B | (m) | $1.40B | $8.14B | (m) |
| 2012-12-31 | $9.31B | (m) | $1.31B | $8.00B | (m) |
| 2012-09-30 | $9.42B | (m) | $1.36B | $8.06B | (m) |
| 2012-06-30 | $11.75B | (m) | $3.87B | $7.88B | (m) |
| 2012-03-31 | $11.54B | (m) | $3.66B | $7.89B | (m) |
| 2011-12-31 | $9.12B | (m) | $1.38B | $7.74B | (m) |
| 2011-09-30 | $11.88B | (m) | $4.02B | $7.86B | (m) |
| 2011-06-30 | $9.18B | (m) | $1.57B | $7.61B | (m) |
| 2011-03-31 | $9.18B | (m) | $1.76B | $7.42B | (m) |
| 2010-12-31 | $8.55B | (m) | $1.67B | $6.87B | (m) |
| 2010-09-30 | $10.07B | (m) | $2.92B | $7.14B | (m) |
| 2010-06-30 | $8.88B | (m) | $2.00B | $6.88B | (m) |
| 2010-03-31 | $8.58B | (m) | $1.81B | $6.76B | (m) |
| 2009-12-31 | $7.80B | (m) | $1.61B | $6.19B | (m) |
| 2009-09-30 | $7.35B | (m) | $1.45B | $5.90B | (m) |
| 2009-06-30 | $6.17B | (m) | $1.59B | $4.58B | (m) |
| 2009-03-31 | (m) | (m) | $1.91B | (m) | (m) |
| 2008-12-31 | $6.17B | (m) | $1.97B | $4.20B | (m) |
| 2008-09-30 | (m) | (m) | $1.54B | (m) | (m) |
| 2008-06-30 | (m) | (m) | $1.17B | (m) | (m) |
| 2007-12-31 | (m) | (m) | $2.04B | (m) | (m) |
| 2006-12-31 | (m) | (m) | $1.74B | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |